Prevention of type 2 diabetes: A review

Diabetes Research and Clinical Practice

Volumn 76, Issue 3, 2007, Pages 317-326

  Hussain, A ^a   Claussen, B ^a   Ramachandran, A ^b   Williams, R ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b Diabetes Research Centre Tamil Nadu   (India)

^c UNIVERSITY OF WALES   (United Kingdom)

Author keywords

Prevention; Review; Type 2 diabetes

Indexed keywords

ACARBOSE; GLICLAZIDE; METFORMIN; PHENFORMIN; TETRAHYDROLIPSTATIN; TOLBUTAMIDE; TROGLITAZONE;

BREAST FEEDING; CALORIC INTAKE; DIET; ETHNIC GROUP; EXERCISE; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LARGE FOR GESTATIONAL AGE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PREGNANCY DIABETES MELLITUS; PROPHYLAXIS; REVIEW; RISK FACTOR; SMALL FOR DATE INFANT;

ADULT; BOTTLE FEEDING; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; FOOD HABITS; GLUCOSE INTOLERANCE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN RESISTANCE; MOTOR ACTIVITY; OBESITY; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTORS;

EID: 33947717552     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.09.020     Document Type: Review

References (70)

1. King H., and Rewers M. Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group. Bull. World Health Organ. 69 (1991) 643-648
2. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diab. Care 21 (1998) 1414-1431
3. Centres for Disease Control. National Diabetes Fact Sheet, 2002. http://www.cdc.gov/diabetes/pubs/factsheet.htm.
4. Eriksson J., Lindstrom J., and Tuomiletho J. Potential for the prevention of type 2 diabetes. Br. Med. Bull. 60 (2001) 183-199
5. Ludwig D.S., and Ebbeling C. Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA 286 (2001) 1427-1430
6. L. Ritchie, S. Ivey, M. Masch, G. Woodward-Lopez, J.P. Ikeda, P.B. Crawford, Pediatric Overweight: a Review of the Literature. Conducted by the Center for Weight and Health, University of California, Berkeley. Prepared for the California Department of Health Services, Childhood Obesity Prevention Initiative, 2001. http://www.nature.berkley.edu/cwh/PDFs/Full-COPI-secure.pfd.
7. Arita Y., Kihara S., Ouchi N., Takashi M., Maeda K., Mivagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
8. Nemet D., Wang P., Funahashi T., Matsuzawa Y., Tanaka S., Engelman L., et al. Adipocytokines, body composition and fitness in children. Pediatr. Res. 53 (2003) 148-152
9. McGarry J.D. Banting Lecture, 2001, Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
10. Blair S.N., and Brodney S. Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues. Med. Sci. Sports Exerc. 31 (1999) 646-662
11. Vuori I. Health benefits of physical activity with special reference to interaction with diet. Diabetes 44 (1995) 1010-1020
12. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
13. Eriksson K.F., and Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34 (1991) 891-898
14. Tuomiletho J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
15. Gutin B., Barbeau P., Owens S., Lemmon C.R., Bauman M., Allison J., et al. Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. Am. J. Clin. Nutr. 75 (2002) 818-826
16. Abate N., and Chandalia M. Ethnicity and type 2 diabetes: focus on Asian Indians. J. Diab. Complications 15 (2001) 320-327
17. Vuori I. Health benefits of physical activity with special reference to interaction with diet. Diabetes 44 (1995) 1010-1020
18. Sherwood N.E., Jeffery R.W., French S.A., Hannan P.J., and Murray D.M. Predictors of weight gain in the Pound of Prevention study. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 395-403
19. Lluch A., Herbeth B., Mejean L., and Siest G. Dietary intakes, eating style and overweight in the Stanislas Family Study. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 1493-1499
20. Reaven G.M. Diet and syndrome X. Curr. Atheroscler Rep. 2 (2000) 503-507
21. Franz M.J., Bantle J.P., Beebe C.A., Brunzell J.D., Chiasson J.L., Garg A., et al. Evidence based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 26 (2003) S51-S61
22. International Diabetes Federation. Consensus on the Aetiology of Type 2 Diabetes Mellitus. Colombo, Sri Lanka. June 6-7, 2002. http://www.idf.org/home/index.cfm?node=444
23. Veening M.A., Van Weisenbruch M.M., and Delemarre-Van De Waal H.A. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J. Clin. Endocrinol. Metab. 87 (2002) 4657-4661
24. Dabelea D., Pettitt D.J., Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diab. Care 22 (1999) 944-950
25. Li C., Johnson M.S., and Goran M.I. Effects of low birth weight on insulin resistance syndrome in Caucasian and African-American children. Diab. Care 24 (2001) 2035-2042
26. Innes K.E., Byers T.E., Marshall J.A., Baron A., Orleans M., and Hamman R.F. Association of a woman's own birth weight with subsequent risk for gestational diabetes. JAMA 287 (2002) 2534-2541
27. Hales C.N., and Barker D.J. The thrifty phenotype hypothesis. Br. Med. Bull. 60 (2001) 5-20
28. Neel J.V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?. Am. J. Hum. Genet. 14 (1962) 353-362
29. Strauss R.S. Effects of the intrauterine environment on childhood growth. Br. Med. Bull. 53 (1997) 81-95
30. Jovanovic L. A tincture of time does not turn the tide: type 2 diabetes trends in offspring of type 2 diabetic mothers. Diab. Care 23 (2000) 1219-1220
31. Van Assche F.A., Holemanszka K., and Aerts L. Long-term consequences for offspring of diabetes during pregnancy. Br. Med. Bull. 60 (2001) 173-182
32. Rosenbloom A. Fetal growth, adrenocortical function and the risk for type 2 diabetes. Pediatr. Diab. 1 (2000) 150-154
33. Ananth C., and Wen S. Trends in fetal growth among singleton gestations in the United States and Canada, 1985 through 1988. Semin. Perinatol. 26 (2002) 260-267
34. Kramer M.S., Morin I., Yang H., Platt R.W., Usher R., McNamara H., et al. Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J. Pediatr. 141 (2002) 538-542
35. Dyck R.F., Klomp H., and Tan L. From "thrifty genotype" to "hefty fetal phenotype": the relationship between high birthweight and diabetes in Saskatchewan Registered Indians. Can. J. Public Health 92 (2001) 340-344
36. Wei J.N., Sung F.C., Li C.Y., Chang C.H., Lin R.S., Lin C.C., et al. Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care 26 (2003) 343-348
37. Lindsay R.S., Hanson R.L., Bennett P.H., and Knowler W.C. Secular trends in birth weight, BMI, and diabetes in the offspring of diabetic mothers. Diab. Care 23 (2000) 249-254
38. Lu G.C., Rouse D.J., Dubard M., Cliver S., Kimberlin D., and Hauth J.C. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am. J. Obstet. Gynecol. 185 (2001) 845-849
39. Pettitt D.J., and Knowler W.C. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diab. Care 21 Suppl. 2 (1998) B138-B141
40. Whitaker R.C., and Dietz W.H. Role of the prenatal environment in the development of obesity. J. Pediatr. 132 (1998) 768-776
41. Silverman B.L., Rizzo T.A., Cho N.H., and Metzger B.E. Long-term effects of the intrauterine environment. The Northwestern University Diabetes Pregnancy Center. Diab. Care 21 Suppl. 2 (1998) B142-B149
42. Whitaker R.C., and Dietz W.H. Role of the prenatal environment in the development of obesity. J. Pediatr. 132 (1998) 768-776
43. Pettitt D.J., Forman M.R., Hanson R.L., Knowler W.C., and Bennett P.H. Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet 350 (1997) 166-168
44. Young T.K., Martens P.J., Taback S.P., Sellers E.A., Dean H.J., Cheang M., et al. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native Canadians. Arch. Pediatr. Adolesc. Med. 156 (2002) 651-655
45. Rose G. Sick individuals and sick populations. Int. J. Epidemiol. 14 (1985) 32-38
46. McKinlay J. A case for refocusing upstream: the political economy of sickness. In: Enelow A., and Henderson J.B. (Eds). Behavioural Aspects of Prevention (1975), American Heart Association, Seattle, Washington
47. King H., and Dowd J.E. Primary prevention of Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33 (1990) 3-8
48. Stern M. Kelly West Lecture. Primary prevention of Type II diabetes mellitus. Diab. Care 14 (1991) 399-410
49. Zimmet P. Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?. J. Int. Med. 247 (2000) 301-310
50. Sartor G., Schersten B., Carlstrom S., Melander A., Norden A., and Persson G. Ten-year follow-up of subjects with impaired glucose tolerance. Prevention of diabetes by Tolbutamide and diet regulation. Diabetes 29 (1980) 41-49
51. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., and Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 (2006) 289-297
52. Dyson P.A., Hammersley M.S., Morris R.J., Holman R.R., Turner R.C., and The Fasting Hyperglycaemia Study Group. The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism 46 (1997) 50-55
53. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program, Baseline characteristics of the randomized cohort. Diab. Care 23 (2000) 1619-1629
54. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of Type 2 Diabetes mellitus in the diabetes prevention program. Diab. Care 26 (2003) 36-47
55. Chiasson J.L., Gomis R., Hanefeld M., Josse R.G., Karasik A., Laakso M., and The STOP-NIDDM Trial Research Group. The STOP-NIDDM Trial. An international study on the efficacy of an (-glucosidase inhibitor to prevent Type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary data. Diab. Care 21 (1998) 1720-1725
56. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of Type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
57. Hanefeld M., Josse R.G., Gomis R., Karasik A., Laakso M., and Chiasson J.L. Efficacy of acarbose to prevent Type 2 diabetes is different in subgroups of subjects with impaired glucose tolerance: The STOP-NIDDM trial. Diabetologia 45 (2002) 104-105
58. Chiasson J., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose can prevent Type 2 diabetes and cardiovascular disease in subjects with impaired glucose tolerance: The STOP-NIDDM trial. Diabetologia 45 (2002) 104
59. Holman R.R., North B.U., and Tunbridge F.K.E. Possible prevention of Type 2 diabetes with acarbose or metformin. Diab. Med. 17 S1 (2000) 17
60. Holman R.R., Blackwell L., Stratton I.M., Manley S.E., Tucker L., and Frighi V. Six-year results from the Early Diabetes Intervention Trial. Diab. Med. 20 (2003) S15
61. Azen S.P., Peters R.K., Berkowitz K., Kjos S., Xiang A., and Buchanan T.A. TRIPOD (TRoglitazone In the Prevention of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin. Trials 19 (1998) 217-231
62. Sjostrom L., Torgerson J.S., Hauptman J., and Boldrin M. XENDOS (XENical in the prevention of Diabetes in Obese Subjects): a landmark study. 9th International Congress on Obesity. Sao Paulo, Brazil (2002)
63. M.J. Davies, J.R. Tringham, J. Troughton, K.K. Khunti, Prevention of type 2 diabetes mellitus. A review of the evidence and its application in a UK setting, Diab. Med. 21 (5) 403-414.
64. Ritchie L.D., Ganapathy S., Woodward-Lopez G., Gerstein D.E., and Fleming S.E. Prevention of type 2 diabetes in youth: Etiology, promising interventions and recommendations. Pediatr. Diab. 4 4 (2003) 174-209
65. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of Type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2
66. Hanefeld M., Josse R.G., Gomis R., Karasik A., Laakso M., and Chiasson J.L. Efficacy of acarbose to prevent Type 2 diabetes is different in subgroups of subjects with impaired glucose tolerance: the STOP-NIDDM trial. Diabetologia 45 (2002) S104-S105
67. Holman R.R., North B.U., and Tunbridge F.K.E. Possible prevention of Type 2 diabetes with acarbose or metformin. Diab. Med. 17 (2000) S1
68. Holman R.R., Blackwell L., Stratton I.M., Manley S.E., Tucker L., and Frighi V. Six-year results from the Early Diabetes Intervention Trial. Diab. Med. 20 (2003) S15
69. Azen S.P., Peters R.K., Berkowitz K., Kjos S., Xiang A., and Buchanan T.A. TRIPOD (TRoglitazone In the Prevention of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin. Trials 19 (1998) 217-231
70. Sjostrom L., Torgerson J.S., Hauptman J., and Boldrin M. XENDOS (XENical in the prevention of Diabetes in Obese Subjects): a landmark study. 9th International Congress on Obesity. Sao Paulo, Brazil (2002)